About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

9.245 +0.455 (+5.18%)

Streaming Delayed Price Updated: 9:59 AM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners ↗

November 06, 2023

Roku vaulted 50% to become Ark Innovation's top holding.

Via Investor's Business Daily

3 No-Brainer Stocks to Buy With $50 Right Now ↗

October 31, 2023

These stocks have declined in the double digits over the past few months.

Via The Motley Fool

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too ↗

October 23, 2023

The three companies are positioned to benefit from red-hot trends.

Via The Motley Fool

Hidden Gems: 3 Stealthy AI Stocks Quietly Conquering the 2023 Market ↗

October 22, 2023

Twilio, UiPath, and Ginkgo Bioworks are all massively underrated opportunities in artificial intelligence.

Via The Motley Fool

Topics Artificial Intelligence

Cathie Wood Just Doubled Down on This Biotech Stock. Should You Follow Her Lead? ↗

October 21, 2023

Cathie Wood has bought over 5 million shares in Ginkgo Bioworks so far this month.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

October 19, 2023

The growth-focused money manager added to these three existing positions on Wednesday.

Via The Motley Fool

This Cathie Wood Stock Could Soar 140%, Wall Street Says. Is That Too Optimistic? ↗

October 18, 2023

Some of the world's biggest pharma companies are partnering with Ginkgo.

Via The Motley Fool

2 Growth Stocks That Could Double Your Money, According to Wall Street ↗

October 15, 2023

Find out why investment bank analysts are pounding the table on these stocks.

Via The Motley Fool

2 Exciting Biotech Stocks to Buy With Less Than $10 ↗

October 11, 2023

You can pick up these stocks for a song right now.

Via The Motley Fool

Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Aviation, CRISPR Shares ↗

October 09, 2023

Via Benzinga

3 Biotech Stocks Ready to Break Out in 2024 ↗

October 07, 2023

These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI.

Via InvestorPlace

Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price ↗

October 04, 2023

Via Benzinga

3 Promising Cathie Wood Stocks That Will Make Early Investors Rich ↗

October 04, 2023

Although the innovation space is getting squirrelly, these Cathie Wood stocks to make you rich provide compelling narratives.

Via InvestorPlace

2 Magnificent Growth Stocks to Buy Right Now ↗

October 04, 2023

These two biotech stocks could be big winners for patient investors.

Via The Motley Fool

Wall Street Says Ginkgo Bioworks Stock Will Soar 132%, and Cathie Wood's Buying It. Should You? ↗

October 04, 2023

It's not a stock for the faint of heart, but its ambitious vision might pay off.

Via The Motley Fool

3 Stocks Wall Street Thinks Can Nearly Double -- and Why They Might Be Dead Wrong ↗

October 04, 2023

Investors should be careful with these stocks, because their potential may not be as promising as their price targets suggest they are.

Via The Motley Fool

3 Healthcare Stocks to Keep an Eye On ↗

October 03, 2023

These three lesser-known healthcare companies have strong growth potential.

Via The Motley Fool

Why Ginkgo Bioworks Stock Is Surging Higher Today ↗

September 27, 2023

A new collaboration with Pfizer is fueling a rally in the company's shares today.

Via The Motley Fool

MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday ↗

September 27, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

MMAT Stock Alert: The $6.2 Million Reason Meta Materials Is Up Today ↗

September 27, 2023

Meta Materials stock is getting a boost on Wednesday as investors in MMAT react positively to $6.2 million in new product orders.

Via InvestorPlace

These 2 Stocks Are Getting Smart Investors' Attention Wednesday ↗

September 27, 2023

Big movers in either direction can give hints about broader market sentiment.

Via The Motley Fool

Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why ↗

September 27, 2023

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Wednesday after the company announced a collaboration with Pfizer Inc (NYSE: PFE) focused on the

Via Benzinga

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer ↗

September 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Via InvestorPlace

Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving ↗

September 27, 2023

Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs

Via InvestorPlace

2 Beaten-Down Growth Stocks That Could Rocket 107% to 127% Higher, According to Wall Street ↗

September 26, 2023

These stocks have taken a tumble, but the investment bank analysts who follow them still think they can produce eye-popping returns.

Via The Motley Fool

These 2 Growth Stocks Are Down More Than 20%, but Billionaires Are Buying Them Hand Over Fist ↗

September 23, 2023

Some of the world's most successful investors are buying millions of shares of these growth stocks.

Via The Motley Fool

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend ↗

September 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

September 22, 2023

The widely followed growth investor keeps adding to some of her top holdings.

Via The Motley Fool

Cathie Wood's Ark Invest Sells Tesla Shares Worth $15.9M, Bolsters Positions In Palantir By $14.9M ↗

September 21, 2023

Via Benzinga

Cathie Wood's Ark Offloads Tesla Shares Worth $8.4M While Staying Bullish On Elon Musk's EV Company ↗

September 20, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Sections

Services

Contact Information

Follow Us